TP53 and cancer: For instance, Yeh et al. demonstrated that screening newborns for eleven genes associated with pediatric cancer predisposition syndromes, including TP53, could lead to a remarkable 53.5% reduction in cancer-related deaths through adherence to surveillance protocols, with a 7.8% reduction in cancer deaths in the first 20 years of life [15].